Medication info
PitanoPen Tablet 2/145 mg (Pitavastatin Calcium, Fenofibrate)

PitanoPen Tablet 2/145 mg (Pitavastatin Calcium, Fenofibrate)

Prescription medicationTabletOral
Ingredient · strength
Fenofibrate›145mg / 1 tabletPitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
Il Sung IS Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202503281 · Approved 2025.12.15

Summary

Main use
Treatment of mixed dyslipidemia
Who takes it
Adults
Adult dose
Take 1 tablet once daily as the recommended dose, with or without food.

Ingredients

Manufacturer
Il Sung IS Co., Ltd.

Efficacy & effects

Treatment of mixed dyslipidemia

  • LDL cholesterol levels
  • triglyceride levels
  • HDL cholesterol levels
  • mixed dyslipidemia
View approved original text

This medication effectively lowers LDL cholesterol in adult patients at high risk for coronary artery disease, helping to reduce the risk of cardiovascular disease. However, it is used in patients with mixed dyslipidemia who have high triglyceride levels and low HDL cholesterol levels. This contributes to an overall improvement in blood lipid levels, maintaining cardiovascular health. Therefore, this medication is effectively used for the treatment of mixed dyslipidemia.

How to take

Adult dose

Take 1 tablet once daily as the recommended dose, with or without food.

Precautions

This medication is used to lower blood lipids. Patients should immediately inform their doctor if symptoms such as muscle pain, muscle weakness, or muscle cramps occur while taking this drug. Particularly, caution is required for elderly individuals, women, those with impaired kidney function, those with uncontrolled hypothyroidism, and those who consume a lot of alcohol. This medication can affect liver function, so regular liver function tests should be conducted before and during use. Also, individuals with moderate to severe renal impairment should not take this medication. This medication is not administered to individuals with a history of pancreatitis, gallbladder disease, liver disease, or myopathy. Women who are pregnant or may become pregnant, and breastfeeding women should not take this medication. If used with other lipid-lowering agents or specific medications, the risk of muscle damage may increase, so consult a doctor. Dizziness may occur while driving or operating machinery, so be cautious. No specific antidote is available in case of overdose, so if suspected, visit a hospital immediately. This medication has not been evaluated for safety and efficacy in children and is not used in them. Medications should be kept out of reach of children and stored in their original container.

Side effects

Pharyngitis, upper respiratory infection, increased ALT, increased AST, increased GGT, abnormal liver function tests, gastroesophageal reflux disease, nausea, headache, dizziness, increased CPK, hypertension, chronic gastritis, erosive gastritis, decreased hemoglobin, decreased white blood cell count, decreased platelet count, decreased granulocyte count, decreased white blood cells, increased eosinophils, increased white blood cells, elevated globulin, positive Coombs test, hypersensitivity, headache, fatigue, dizziness, stiffness, drowsiness, insomnia, heaviness, paralysis, thromboembolism, interstitial lung disease, gastrointestinal symptoms (abdominal pain, nausea, vomiting, diarrhea, bloating), pancreatitis, dry mouth, indigestion, abdominal bloating, constipation, stomatitis, loss of appetite, glossitis, nausea, gastric discomfort, increased transaminases, cholelithiasis, jaundice, complications of cholelithiasis, elevated bilirubin, increased cholinesterase, increased AST, increased ALT, increased γ-GT, increased ALP, increased LDH, decreased aldosterone, increased aldosterone, increased adrenocorticotropic hormone, increased cortisol, decreased testosterone, severe skin reactions, skin hypersensitivity, rash, itching, urticaria, alopecia, photosensitivity, muscle disorders, myalgia, myositis, muscle cramps, muscle weakness, rhabdomyolysis, myopathy, increased myoglobin, increased CPK, weakness, increased urination, increased BUN, elevated serum creatinine, sexual dysfunction, increased blood homocysteine levels, increased hematuria, palpitations, fatigue, skin pain, burning sensation, arthralgia, edema, blurred vision, photophobia, hearing loss, urinary hematuria, increased uric acid levels, elevated serum potassium and phosphate levels, taste disturbances, colored urine, lethargy, positive antinuclear antibodies, hair loss, hypersensitivity, urticaria, erythema, angioedema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is best to store the medication at room temperature between 1°C to 30°C, avoiding excessively hot or cold places.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.